PofoliaShared via Pofolia

Journal of the American Society of Nephrology· 2017Q1

Cell-Free DNA and Active Rejection in Kidney Allografts

Roy D. Bloom, Jonathan S. Bromberg, Emilio D. Poggio, Suphamai Bunnapradist et al.

Short summary

Donor-derived cell-free DNA (dd-cfDNA) in blood can noninvasively differentiate kidney transplant rejection from other injuries, with levels above 1.0% indicating a probability of active rejection.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Sign in on the web to open

Field: Transplantation

TransplantationMedicine